Молекулярные и клеточные механизмы иммунопатологии при бронхиальной астме

1. Беклемишев Н.Д. Т-хелпер 2 — ключевая клетка противометазойного иммунитета и реакций аллергии немедленного типа / / Иммунология.— 1995.— № 5.— С.4 — 9.

2. Бронхиальная астма. Глобальная стратегия. Совместный доклад Н И З (СШ А) и В О З (1993) / / Пульмонология .— 1996.— Приложение.— С.2—8.

3. Воспаление / Под ред. В.В. Серова, B.C. Паукова.— М.: Медицина, 1995.— 640 с.

4. Медуницын Н.В. Цитокины и аллергия, опосредованная IgE / / Иммунология.— 1993.— № 5.— С . 11 — 13.

5. Потапнев М.П. Цитокиновая сеть нейтрофилов при воспалении / / Там ж е .— 1995.— № 4.— С.34 — 40.

6. Ackerman V., Marini М., Vittori Е. et al. Detection of cytokines and their sources in bronchial biopsy specim ents from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness / / Chest.— 1994.— Vol.105, № 3 . — P.687—696.

7. Agostini C., Sancetta R., Cerutti A. et al. Alveoiar macrophages as a cell source of cytokine hyperproduction in HIV-related lung disease / / J. Leukoc. Biol.— 1995.— Vol.58, № 5.— P.495—500.

8. Alatn R., York J., Boyars M. et al. Increased MCP-1, RANTES and M I P - la in bronchoalveoiar fluid of allergic asthmatic patients / / Am. J. Respir. Crit. Care M ed .— 1996.— Vol. 153, № 4.— P.1398—1404.

9. Bissonnette E.Y. Histamine inhibits tumor necrosis factor # a release by mast cells through H2 and H3 receptors / / Am. J. Respir. Cell. Mol. Biol.— 1996.— Vol. 14, № 6.— P.620—626.

10. Bradding P., Roberts J.A., Britten К.M. et al. Interleukin-4, -5 and -6 and tu m o r necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines / / Ibid.— 1994.— V ol.10, № 5.— P.471—480.

11. Corticosteroid action and resistancein asthm a / / Am. J. Respir. Crit. Care Med.— 1996.— Vol.154, № 2.— Pt 2, Suppl.— P.s79.

12. Cox G., Gauldie J., Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro / / Am. J. Respir. Cell. Mol. Bioi.— 1992.— Vol.7, № 5.— P.507—513.

13. Czarny D. Asthma and allergy. What is the connection? / / Aust. Fam. Physician.— 1993.— Vol.22, № 11.— P. 1967—1970.

14. Djukanovic R., Wilson J.W., Britten K.M. et al. Quantitation of mast cell and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochem istry / / Am. Rev. Respir. Dis.— 1990.— Vol. 142, № 4.— P.863—871.

15. Erb K.J., Le Gros G. The role of Th2 type C D 4+ T cells and TH2 type CDS’1' cells in asthma / / Immunol. Cell. Biol.— 1996.— Vol.74. № 2.— P.206—208.

16. Fukuda T., Asakawa J., Motojima S., Makino S. Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma / / Ann. Allergy A sthm a Immunol.— 1995.— Vol.75, № 1.— P.65—72.

17. Fukuda T., Fukushima Y., Numao T. et al. Role of IL-4 and Vascullar Cell Adhesion Molecuie-1 in selective eosinophil migration into the airways in allergic asthma / / Am. j. Respir. Cell Mol. Biol.— 1996.— Vol.14, № 1.— P.84—94.

18. Gagro A., Ratatic S. Allergen-induced CD23 on CD4^ T lymphocytes and CD21 in B lymphocytes in patients with allergic asthma: evidence and regulation / / Eur. J. Immunol.— 1994.— Vol.24, № 5.— P.l109—1114.

19. Garlisi C.G., Falcone A., Billah M.M., Egan R.W., Uinland S.P. Ncell are the predominant source of interleukin-5 but not interieukin-4 mRNA expression in the lungs of antigen-challenged allergic mice / / Am. J. Respir. Cell Mol. Biol.— 1996.— Vol. 15, № 3.— P.420—428.

20. Guidot D.M., Stevens E.E., Repine M.J. et al. Intratracheal but not intravascuiar interleukin-1 causes acute edemato us injury in isolated neutrophil — perfused lung through an oxygen radical — mediated mechanism / / J. Lab. Clin. Med.— 1994.— Vol. 123, No 4.— P.605—609.

21. Hallsworth M.P., Son C.P., Lane J.P. et al. Selective production of G M -C SF , TNF-alpha, IL-1 beta and IL-8 production by monocytes and macro phages of asthmatic subjects / / Eur. Respir. J.— 1994.— Vol.7, № 6 .— P. 1096—1102.

22. Holt P. Developmental immunology and host defense. Kinetics of postnatal maturation of immune competence as a potential etiologic factor in early chidhood asthma / / Am. J. Respir. Crit. Care Med .— 1995.— Vol.151, № 2.— P t 2, Suppl.— P. sll—sl3.

23. Hope J.C., Dearman R.J., Kimber I., Hopkins S.J. Differential kinetics of IL-4 production by draining lymph node cells following topical exposure of mice to contact and respiratory allergens / / Cytokine.— 1995.— Vol.7, № 6.— P.629.

24. Hoshi H., Ohno I., Honma M. et a l. IL-5, IL-8 and GM -CSF im munostaining of sputum cells in bronchial asthma and chronic bronchitis / / Clin. exp. Allergy.— 1995.— Vol.25. № 8.— P.720—728.

25. Huang S.-K., Xiao H.-Q., Kleine-Tebbe J. et al. IL-13 expression at the sites of allergen challenge in patients with asthma / / J. Immunol.— 1995.— Vol. 155, № 5.— P.2688—2694.

26. Kaneko M., Swanson M.C., Gleich G.J., Kita H. Allergen-specific igG l and lgG3 through Fc gamma Rii induce eosinophil degranulation / / J. Clin. Invest.— 1995.— Vol.95, № 6.— P.2813—2821.

27. Kline J.N., Hunninghake G.W. T-lympiiocyte dysregulation in asthma / / Proc. Soc. Exp. Biol. M e d .— 1994.— Vol.207, № 3.— P.243—253.

28. Knochel B., Luttman W., Forsster M., Matthys H., Virchow J.C., Kroegel C. Survivalenhancing activity of interleukin-13 in human eosinophils. Comparison to interleukin-4 and granuo cyte/m acrophage colony-stimulating factor / / Eur. Respir. J.— 1996.— Vol.9. Suppl.23.— P.450s (2792).

29. Kroegel C., Liu M.C., Hubbard W.C. et al. Blood and bronc'noalveoiar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production / / J. Aliergy Clin. Immunoi.— 1994.— Vol.93, № 4,— P.725—734.

30. Kuna P. Chemokines in allergic inflammation. Progress in asthma and allergy / / Centra"! and Eastern European Conference on Asthma, Allergy and Clinical Immunology / Ed. M. Kowalski. Proceedings.— Lodz, 1996.— P.l12—120.

31. Linden A. (3-Adrenoreceptor agonists increase interleukin-8 production in human bronchial epithelial cells / / Eur. Respir. J.— 1996.— Vol.9, Suppl.23.— P. 124s (P0831).

32. Levine S.J. Bronchial epithelial cell-cytokine interactions in airway inflammation / / J.Invest. Med.— 1995.— Vol.43.— P.241—249.

33. Lock S.H., Kay A.B., Barnes N.C. Double-blind, placedo-controlIed study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma / / Am. J. Respir. Crit. Care Med.— 1996,— Vol.153, № 2.— P.509—514.

34. Mengelers H.J., Maikoe T., Brinkman L. et al. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics / / Ibid.— 1994.— Vol. 149, № 2.— Pt 1.— P.345—351.

35. Montefort S., Gratziou C., Goulding D. et a l. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyteendothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways / / J. Clin. Invest.— 1994.— Vol.93, № 4.— P.1411—1421.

36. Mudde G.C., Reischl I.G., Corvaia N., Hren A., Poellabauer E.-M. A ntigen presentation in allergic sensitization / / Immunol Cell Biol.— 1996.— Vol.74, № 2.— P.167—173.

37. Nakajitna H., Iwamoto I., Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment f in mouse trachea / / Am . Rev. Respir. Dis.— 1993.— Vol. 148 № 4.— P.l102—1104.

38. Nonaka M., Nonaka R., Jordana M., Dolavich J. GM-CSF, IL-8, IL-1 R. T N F a R and HLA-DR in nasal epithelial cell in allergic rhinitis / / Am. J. Respir. Crit. Care M ed .— 1996.— Vol. 153, № 5.— P.1675—1681.

39. Ohkawara Y., Yamauchi K., Maruyama N. et a l. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1 / VLA-4 interaction in selective eosinophil infiltration / / Am. J. Respir. Cell Mol. Biol.— 1995.— V ol.12, № 1.— P.4—12.

40. Ohno I., Nitta Y., Yamauchi K. et al. Transfonm ing growth factor ß (T G F ßl) gene expression by eosinophils in asthmatic airway inflamation / / Ibid.— 1996.— Vol. 15, № 3 .— P.404—409.

41. Rak S. The m echanism of specific immunotherapy in allergic disease caused by inhaled allergen / / Central and Eastern European Conference on Asthma. Allergy and Clinicfl Immunology / Ed. M. Kowalski: Proceedings.— Lodz, 1996.— P. 179—184.

42. Reed C.E. The im portance of eosinophils in the immunology of & asthma and allergic disease / / Ann. Allergy.— 1994.— Vol.74, № 4.— P.376—380.

43. Renzi P.M., Yang J.P., Diamantstein T., Martin J.G. Effects of depletion of cells bearing the interleukin-2 recepto r in immunoglobulin production and allergic airway responses in the rat / / Am . J. Respir. Crit. Care M e d .— 1996.— Vol. 153, № 4.— P.1214—1221.

44. Romagnani S. Human TH1 and Th2 subsets: doubt no more / / Immunol. Today.— 1991.— Vol.12, № 8.— P.256—257.

45. Shakib F., Smith S.J. In vitro basophil histam ine-releasing activity of circulating IgGi and IgG4 autoanti-IgE antibodies from asthma patients and the demonstration that anti-IgE modula tes allergeninduced basophil activation / / Clin. Exp. Allergy.— 1994.— Vol.24, № 3.— P.270—275.

46. Shuaib Nasser S.M., Pfister R., Christie P.E. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects / / Am. J. Respir. Crit. Care Med.— 1996.— Vol. 153, № 1.— P.90—96.

47. Sim T.C., Grant A., Hilsmeier K.A., Fukuda Y., Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after . antigen challenge / / Ibid.— 1994.— Vol. 149, № 2.— P.339—344.

48. Smith R.E., Strieter R.M., Zhang K. et a l. A role for C-C chemokines in fibrotic lung disease / / J. Leukoc. Biol.— 1995.— Vol.57, No 5,— P.782—787.

49. Spiegelberg H.L., Beck L., Stevenson D.D., Ishioka G.Y. Recognition of T-cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I — specific human T cell clones / / J. Immunol.— 1994.— Vol.152, № 9.— P.4706—4711.

50. Spiteri M.A., Knight R.A., Jeremy J.Y. et al. Alveolar macrophage-induced suppression of peripheral blood mononuclear responsiveness is reversed by in v itro allergen exposure in bronchial asthma / / Eur. Respir. J .— 1994.— Vol.7, № 8.— P. 1431 — 1438.

51. Swain S.L. CD4 T cell development and cytokine polarization: an overview / / J. Leukoc. Biol.— 1995.— Vol.57, № 5.— P.795—798.

52. Till S., Li B., Durham S. et al. Secretion of the eosinophol-active cytokines interleukin-5, granulocute/m acrophage colony-stimulating factor and interleukin-3 by bronchoaiveoiar lavage CD4'*' and C D 8 + T cell line in atopic asthm acics, and atopic and nonatopic controls / / Eur. J. Immunol.— 1995.— Vol.25. № 10.— P.2727—2731.

53. Vignola A.M., Chanez P., Paul-Lacoste P. et al. Phenotypic and functional modulation of norman alveolar macrophage s by hista- (mine / / Am. J. Respir. Cell. Mol. Biol.— 1994.— Vol. 11, № 4.— P.456—463.

54. Virchow J.C., Walker C., Hafner D. et al. T cells and cytokines in bronchoalveolar lavage fluid after segm ental allergen provocation in atopic asthma / / Am. J. Respir. Crit. Care M e d .— 1995.— Voi. 151, № 4 .— P.960 — 968.

55. Walker C., Bauer W., Braun R.K. et al. Activated T cell and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia / / ibid.— 1994.— Vol. 150, № 4 .— P.1038 — 1048.

56. Wang J.H., Devalia J.L., Xia L., Sapsford R.J., Daves R.J. Expression of RANTES by human bronchial eputhelial cells in vitro and in vivo and the effect of corticosteroids / / Am. J. Respir. Cell. Mol. Biol.— 1996.— Vol.14. № 1.— P.27—35.

57. Wardlaw A.J. Eosinophils in the 1990-s: new perspectives in their role in the health and disease / / Postgrad. Med. J .— 1994.— Vol.70, № 826.— P.536—552.

58. Werfel S.J., Yednock T.A., Matsumoto K. et al. Functional regulation of ßi integrins on human eosinophils by divalent cations and cytokines / / Am. J. Rrspir. Cell. Mol. Biol.— 1996.— Voi. 14, № 1.— P.44—52.

59. Xiu Q., Fujimura M., Nomura M. et al. Bronchial hyperresponsiveness and airway neutrophil accumulation induced by unterleukin-8 and the effect of the thromboxane A2 antagonist S-1452 in guinea pigs / / Clin. Exp. Allergy.— 1995.— Vol.25, № 1.— P.51—59.